ArticleFrontiers in oncology2021

PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes.

Rui Gou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.